Literature DB >> 18309490

Anemia in monkey collagen-induced arthritis is correlated with serum IL-6, but not TNFalpha.

Yasushi Uchiyama1, Nobuo Koike, Masahiko Mihara.   

Abstract

We characterized the anemia in monkey collagen-induced arthritis (CIA) to evaluate whether this model is useful to analyze the basis of an anemia of inflammatory diseases. Cynomolgus monkey was immunized with bovine type II collagen on days 0 and 21. Blood samples were collected regularly and hematological parameters, biochemical parameters and cytokine levels were monitored. Red blood cell (RBC) counts, hematocrit (Ht), and hemoglobin (Hb) gradually decreased after immunization and reached the bottom on day 35. CRP rose rapidly after first immunization and reached a peak on day 21. Serum iron levels and transferrin (Tf) saturation were dropped after immunization and reached a bottom on day 28. Thereafter it returned to normal. On the other hand, ferritin levels increased after immunization. IL-6 levels showed positive correlation with CRP, and negative correlation with Hb, RBC counts and serum iron, but TNFalpha did not show any correlation. In conclusion, the anemia in monkey CIA is very similar to human anemia of inflammatory diseases concerning the changes of serum parameters. And our data strongly suggest that IL-6 is an essential cytokine for the development of the anemia in monkey CIA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18309490     DOI: 10.1007/s00296-008-0547-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

1.  Anemia of chronic disease: a misnomer.

Authors:  R F Schilling
Journal:  Ann Intern Med       Date:  1991-10-01       Impact factor: 25.391

2.  Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Authors:  R Maini; E W St Clair; F Breedveld; D Furst; J Kalden; M Weisman; J Smolen; P Emery; G Harriman; M Feldmann; P Lipsky
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

3.  Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes.

Authors:  S H Yap; H J Moshage; B P Hazenberg; H M Roelofs; J Bijzet; P C Limburg; L A Aarden; M H van Rijswijk
Journal:  Biochim Biophys Acta       Date:  1991-02-19

4.  Severe iron deficiency anemia in transgenic mice expressing liver hepcidin.

Authors:  Gaël Nicolas; Myriam Bennoun; Arlette Porteu; Sandrine Mativet; Carole Beaumont; Bernard Grandchamp; Mario Sirito; Michèle Sawadogo; Axel Kahn; Sophie Vaulont
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

5.  Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease.

Authors:  M Jongen-Lavrencic; H R Peeters; A Wognum; G Vreugdenhil; F C Breedveld; A J Swaak
Journal:  J Rheumatol       Date:  1997-08       Impact factor: 4.666

6.  Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.

Authors:  N Takagi; M Mihara; Y Moriya; N Nishimoto; K Yoshizaki; T Kishimoto; Y Takeda; Y Ohsugi
Journal:  Arthritis Rheum       Date:  1998-12

Review 7.  Preclinical models of arthritic disease in non-human primates.

Authors:  Michel P M Vierboom; Margreet Jonker; Paul P Tak; Bert A 't Hart
Journal:  Drug Discov Today       Date:  2007-03-08       Impact factor: 7.851

8.  Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.

Authors:  Norihiro Nishimoto; Kazuyuki Yoshizaki; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Shinichi Kawai; Tsutomu Takeuchi; Jun Hashimoto; Junichi Azuma; Tadamitsu Kishimoto
Journal:  Arthritis Rheum       Date:  2004-06

9.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.

Authors:  Elizabeta Nemeth; Seth Rivera; Victoria Gabayan; Charlotte Keller; Sarah Taudorf; Bente K Pedersen; Tomas Ganz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

10.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  7 in total

1.  Relationships between Cytokine Levels and Disease Parameters during the Development of a Collagen-induced Arthritis Model in Cynomolgus Macaques (Macaca fascicularis).

Authors:  Eun Wha Choi; Sungjoo Kim
Journal:  Comp Med       Date:  2019-05-08       Impact factor: 0.982

Review 2.  Animal models of anemia of inflammation.

Authors:  Seth Rivera; Tomas Ganz
Journal:  Semin Hematol       Date:  2009-10       Impact factor: 3.851

3.  Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production.

Authors:  Misato Hashizume; Yasushi Uchiyama; Naoto Horai; Naohisa Tomosugi; Masahiko Mihara
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

Review 4.  Animal Models of Normal and Disturbed Iron and Copper Metabolism.

Authors:  Xiaoyu Wang; Michael D Garrick; James F Collins
Journal:  J Nutr       Date:  2019-12-01       Impact factor: 4.798

5.  The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis.

Authors:  Misato Hashizume; Masahiko Mihara
Journal:  Arthritis       Date:  2011-05-26

Review 6.  Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis.

Authors:  Masahiko Mihara; Yoshiyuki Ohsugi; Tadamitsu Kishimoto
Journal:  Open Access Rheumatol       Date:  2011-02-25

7.  Serum Levels of IL-6 and TNF-α May Correlate with Activity and Severity of Rheumatoid Arthritis.

Authors:  Shi-Tong Wei; Yong-Hua Sun; Shi-Hua Zong; Yong-Bing Xiang
Journal:  Med Sci Monit       Date:  2015-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.